Search

Search Constraints

You searched for: Author/Creator Rush, James S

Search Results

1. Anti-CD40 Antibodies do not Cause Thromboembolism as Demonstrated by in Vitro and in Vivo Studies. (July 2018)

2. Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study. (March 2020)

3. Blockade of CD40–CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome. Issue 7 (22nd July 2019)

4. Blockade of CD40–CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome. Issue 7 (22nd March 2019)